Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE)

BACKGROUND: The objective of the study was to evaluate the efficacy and safety of upadacitinib over 84 weeks in Japanese patients with active rheumatoid arthritis (RA) and an inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs. METHODS: All patients completing a 12-w...

Descripción completa

Detalles Bibliográficos
Autores principales: Kameda, Hideto, Takeuchi, Tsutomu, Yamaoka, Kunihiro, Oribe, Motohiro, Kawano, Mitsuhiro, Yokoyama, Masayuki, Pangan, Aileen L., Konishi, Yuko, Meerwein, Sebastian, Tanaka, Yoshiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789301/
https://www.ncbi.nlm.nih.gov/pubmed/33407801
http://dx.doi.org/10.1186/s13075-020-02387-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789301/
https://www.ncbi.nlm.nih.gov/pubmed/33407801
http://dx.doi.org/10.1186/s13075-020-02387-6

Ejemplares similares